» Articles » PMID: 20398931

Cellular Chemotaxis Induced by Wear Particles from Joint Replacements

Overview
Journal Biomaterials
Date 2010 Apr 20
PMID 20398931
Citations 55
Authors
Affiliations
Soon will be listed here.
Abstract

The destruction of bone around joint replacements (periprosthetic osteolysis) is an adverse biological response associated with the generation of excessive wear particles. Wear debris from the materials used for joint replacements stimulate a chronic inflammatory and foreign body reaction that leads to increased osteoclast differentiation and maturation, and decreased bone formation. Wear debris induces both local and systemic trafficking of inflammatory cells to the site of particle generation. Recent studies have shown that this effect is mediated primarily by chemotactic cytokines (chemokines) including macrophage chemotactic protein-1 (MCP-1, also known as CCL2), macrophage inhibitory protein-1 (MIP-1), Interleukin-8 (IL-8 or CXCL8) and others. These ligands migrate along a concentration gradient to interact with G-protein-linked transmembrane receptors on the cell surface. Chemokines are involved in the innate and adaptive immune responses, angiogenesis, wound healing and tissue repair. In vitro, in vivo and tissue retrieval studies have shown that chemokine-directed systemic trafficking of polymorphonuclear leukocytes and cells of the monocyte/macrophage lineage to wear particles result in the release of pro-inflammatory factors and subsequent bone loss. Modulation of the chemokine ligand-receptor axis is a potential strategy to mitigate the adverse effects of wear particles from joint replacements.

Citing Articles

Alterations in Small Non-coding MicroRNAs (miRNAs) and the Potential Role in the Development of Aseptic Loosening After Total Hip Replacement: Study Protocol for an Observational, Cross-Sectional Study.

Papagiannis S, Tatani I, Kyriakopoulos G, Kokkalis Z, Megas P, Stathopoulos C Cureus. 2024; 16(10):e72179.

PMID: 39583487 PMC: 11582946. DOI: 10.7759/cureus.72179.


Isolated Liner Exchange and Bone Grafting for the Management of Periacetabular Osteolysis in Well-Fixed Cups with an Intact Locking Mechanism at Short-Term to Medium-Term Follow-Up: A Systematic Review.

Ricotti R, Alexander-Malahias M, Ma Q, Jang S, Loucas R, Gkiatas I HSS J. 2024; 20(4):567-576.

PMID: 39494435 PMC: 11528827. DOI: 10.1177/15563316231189736.


Prosthetic Metals: Release, Metabolism and Toxicity.

Zhong Q, Pan X, Chen Y, Lian Q, Gao J, Xu Y Int J Nanomedicine. 2024; 19:5245-5267.

PMID: 38855732 PMC: 11162637. DOI: 10.2147/IJN.S459255.


Angiopoietin 1 Relieves Osteolysis by Promoting Macrophage Mitophagy Through the TBK1-SQSTM1 Pathway to Inhibit AIM2 Inflammasome-Mediated Pyroptosis.

Yin J, Lai P, Zhu L, Ma J Appl Biochem Biotechnol. 2024; 196(11):7908-7927.

PMID: 38662322 DOI: 10.1007/s12010-024-04961-z.


Nano wear particles and the periprosthetic microenvironment in aseptic loosening induced osteolysis following joint arthroplasty.

Xie Y, Peng Y, Fu G, Jin J, Wang S, Li M Front Cell Infect Microbiol. 2023; 13:1275086.

PMID: 37854857 PMC: 10579613. DOI: 10.3389/fcimb.2023.1275086.


References
1.
Taki N, Tatro J, Nalepka J, Togawa D, Goldberg V, Rimnac C . Polyethylene and titanium particles induce osteolysis by similar, lymphocyte-independent, mechanisms. J Orthop Res. 2005; 23(2):376-83. DOI: 10.1016/j.orthres.2004.08.023. View

2.
Trindade M, Schurman D, Maloney W, Goodman S, Smith R . G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 release in vitro. J Biomed Mater Res. 2000; 51(3):360-8. DOI: 10.1002/1097-4636(20000905)51:3<360::aid-jbm9>3.0.co;2-e. View

3.
Jacobs J, Campbell P, Konttinen Y . How has the biologic reaction to wear particles changed with newer bearing surfaces?. J Am Acad Orthop Surg. 2008; 16 Suppl 1:S49-55. DOI: 10.5435/00124635-200800001-00011. View

4.
Schwarz E, Looney R, OKeefe R . Anti-TNF-alpha therapy as a clinical intervention for periprosthetic osteolysis. Arthritis Res. 2000; 2(3):165-8. PMC: 129996. DOI: 10.1186/ar81. View

5.
Tallroth K, Eskola A, Santavirta S, Konttinen Y, Lindholm T . Aggressive granulomatous lesions after hip arthroplasty. J Bone Joint Surg Br. 1989; 71(4):571-5. DOI: 10.1302/0301-620X.71B4.2768299. View